<?xml version="1.0" encoding="ISO-8859-1"?><rss version="0.91" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">

	<channel>
    	<title>rr-research.no</title>
    	<link>http://www.rr-research.no</link>
    	<description>Research news from the Norwegian Radium Hospital and Rikshospitalet</description>
	    <image>
	    	<title>rr-research.no</title>
    		<link>http://www.rr-research.no</link>
			<url>http://www.rr-research.no/design1/gfx/RHlogo-liten.gif</url>
		</image>

<item>
<title><![CDATA[Researchers announce the first comprehensive genome studies of the evolution of 21 breast cancers Untangling the development of breast cancer ]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12471</link>
<description><![CDATA[In two back-to-back reports published online on 17 May in Cell (journal impact factor 32.4) , researchers have sequenced the genomes of 21 breast cancers and analysed the mutations that emerged during the tumours&#8223; development.Led by researchers from the Wellcome Trust Sanger Institute, the team created a catalogue of all the mutations in the genomes of the 21 cancer genomes and identified the mutational processes that lead to breast cancer. They found that these mutations accumulate in breast cells over many years, initially rather slowly, but picking up more and more momentum as the genetic damage builds up.Anita Langerød and Anne-Lise Børresen-Dale (photo) from the Department of Genetics at the Institute for Cancer Research have made strong contributions to this work.]]></description>
<dc:date>2012-05-18T13:59:00Z</dc:date>
</item>
<item>
<title><![CDATA[Actionable Targets in Cancer Metastasis (MetAction) – from Bed to Bench to Byte to Bedside Presentation of prestigious research project]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12467</link>
<description><![CDATA[This research project - entitled "Actionable Targets in Cancer Metastasis - from Bed to Bench to Byte to Bedside" - and focusing on intratumoral heterogeneity and personal-adapted treatment of metastatic melanoma, breast-and colorectal carcinoma - has recently been granted with 22.8 mill NOK from the Norwegian Research Council. The granted project is based in an integrated collaboration between basic research- and clinical departments located either at Oslo University Hospital (OUS) or Akershus University Hospital (Ahus) and is funded for four years. Principle Investigators are Gunhild M. Mælandsmo from Department of Tumor Biology and Anne-Lise Børresen-Dale from the Department of Genetics, both at Institute for Cancer Research, OUS.]]></description>
<dc:date>2012-05-16T13:15:00Z</dc:date>
</item>
<item>
<title><![CDATA[Global Academic Programs 2012 GAP cancer conference in Oslo May 14-16]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12455</link>
<description><![CDATA[The 2012 Global Academic Programs conference is held at Holmenkollen Park Hotel in Oslo from May 14-16. The GAP Annual Conference provides a forum for faculty from  MD Anderson and their sister institutions to develop collaborations and  exchange research results and ideas. The event is held at MD Anderson in odd years and is hosted by a Sister Institution in even years. Starting in 2012, the GAP Annual Conference will travel every other year to a Sister Institution, rotating around different regions of the globe. The first external conference is hosted by the Norwegian Cancer Consortium (NCC), which includes Stavanger University Hospital, The Norwegian Radium Hospital at OUS, and the National Cancer Registry of Norway.All plenary lectures and workshops will be filmed and made available on http://webtv.oncolex.no/ after the conference.]]></description>
<dc:date>2012-05-11T22:49:00Z</dc:date>
</item>
<item>
<title><![CDATA[Trevor Clancy Trial lecture and disputation May 9th]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12443</link>
<description><![CDATA[M. Sc. Trevor Clancy from Eivind Hovig's group at the Department of Tumor Biology at the Institute for Cancer Research will give his trial lecture on Wednesday May 9th at 10.15  on the given subject "Methods of inferring protein complexes from protein-protein interaction data".He will defend his PhD thesis - entitled "Unraveling the complexity of protein networks. Application in tumor immunity" - at 13:15 the same day. Both events will take place in the auditorium in the research building (building K) at OUS-The Norwegian Radium Hospital, Montebello.]]></description>
<dc:date>2012-05-08T13:03:00Z</dc:date>
</item>
<item>
<title><![CDATA[Study by Ane Hansen Kjenseth et al. featured on the cover of Journal of Biological Chemistry ]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12437</link>
<description><![CDATA[A study by PhD student Ane Hansen Kjenseth (photo) and colleagues at Department of Cancer Prevention, Institute for Cancer Research and Centre for Cancer Biomedicine, has identified a novel mechanism for regulation of intercellular communication.  The article was published in the May 4 issue of Journal of Biological Chemistry, and was featured on the cover of the journal.]]></description>
<dc:date>2012-05-07T14:56:00Z</dc:date>
</item>
<item>
<title><![CDATA[Tor Erik Rusten Institute Seminar - Wednesday May 9th]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12435</link>
<description><![CDATA[The institute seminar on Wednesday May 9th will be held by Tor Erik Rusten from the Department of Biochemistry.Title of his talk: Unraveling tumor suppressor and oncogene functions using Drosophila and human organoid modelsiTime and place: 12.00, Auditorium, new research building, Montebello.]]></description>
<dc:date>2012-05-07T12:35:00Z</dc:date>
</item>
<item>
<title><![CDATA[Antoni Wiedlocha and Beata Nadratowska-Wesolowska CCB seminar 10th of May at 13.00 hrs]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12434</link>
<description><![CDATA[Centre for Cancer Biomedicine (CCB) welcomes you to a research seminar on Thursday 10th of May at 13.00 in the Auditorium in the Research Building, the Norwegian Radium Hospital. Lectures will be held by group leader Antoni Wiedlocha and post doc Beata Nadratowska-Wesolowska, both from the Department of Biochemistry at the Institute for Cancer Research.
At 13:00 hrs: Activation and Termination of Fibroblast Growth Factor Induced Cellular Signaling, by Antoni Wiedlocha
At 13:30 hrs: The ribosomal S6 kinase 2 (RSK2) binds and phosphorylates FGFR1, by Beata Nadratowska-Wesolowska
Refreshments are served in the lobby after the seminar]]></description>
<dc:date>2012-05-07T11:32:00Z</dc:date>
</item>
<item>
<title><![CDATA[Kirsten Sandvig appointed "Scientist of the Month" by "Helse Sør-Øst" for April 2012 ]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12427</link>
<description><![CDATA[The South-Eastern Norway Regional Health Authority (Helse S&oslash;r-&Oslash;st) aims to profile ongoing excellent research in the region by by calling special attention to a "Scientist of the month".For the month of March 2012, this honor goes to Kirsten Sandvig from the Department of Biochemstry at the Institute for Cancer Research, Oslo University Hospital.]]></description>
<dc:date>2012-05-03T14:00:00Z</dc:date>
</item>
<item>
<title><![CDATA[Nature article describing 2000 breast tumors reveals new subgroups ]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12414</link>
<description><![CDATA[Department of Genetics has been involved in an article presented in Nature (journal impact factor 36.10). By integrating the copy number and gene expression of 2000 breast tumors, novel subgroups of breast cancer with distinct clinical outcome were revealed. Copy number was associated with expression in ~40% of genes. Co-authors from the Department of Genetics are Anita Langer&oslash;d and Anne-Lise B&oslash;rresen-Dale.]]></description>
<dc:date>2012-04-25T13:52:00Z</dc:date>
</item>
<item>
<title><![CDATA[Magnar Bjørås Institute Seminar - Wednesday April 25th]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12412</link>
<description><![CDATA[The institute seminar on Wednesday April 25th will be held by Magnar Bjørås from Institute of Medical Microbiology, OUS-Rikshospitalet.Title of his talk: DNA repair deficiency in neurodegenerationiTime and place: 12.00, Auditorium, new research building, Montebello.]]></description>
<dc:date>2012-04-24T12:39:00Z</dc:date>
</item>
<item>
<title><![CDATA[Work from Einar K. Rofstad's group presented as "Research project of the month"  Publicity from the Norwegian Cancer Society:]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12409</link>
<description><![CDATA[In the series "Research project of the month", presented by The Norwegian Cancer Society, work performed in Einar K. Rofstad's group at the Department of Radiation Biology, Institute for Cancer Research, the Norwegian Radium Hospital, OUS was selected for April 2012. This project deals with patient adjusted radiation treatment, employing MR techology in the development of methods to identify tumors.]]></description>
<dc:date>2012-04-23T15:04:00Z</dc:date>
</item>
<item>
<title><![CDATA[Oslo University Hospital awards 6 excellent articles for second half-year of 2011 ]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12407</link>
<description><![CDATA[In order to stimulate excellent research and draw attention to the hospital's extensive research activity, Oslo University Hospital reward outstanding publications regularly. Every half-year, six of the very best papers authored by scientists working on the hospital (first or last author must be affiliated to OUS) are selected. The awarded articles from the second half-year of 2011 have been announced.]]></description>
<dc:date>2012-04-19T14:29:00Z</dc:date>
</item>
<item>
<title><![CDATA[Solveig Fossum-Raunehaug Institute Seminar – Wednesday April 18th]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12404</link>
<description><![CDATA[The institute seminar on Wednesday April 18th will be held by Solveig Fossum-Raunehaug from Kirsten Skarstad's group at the Department of Cell Biology. Title of her talk: Spatial organization of newly replicated DNA in Escherichia coliTime and place: 12.00, Auditorium, new research building, Montebello.]]></description>
<dc:date>2012-04-17T12:32:00Z</dc:date>
</item>
<item>
<title><![CDATA[Substantial support from "The Programme for Publicly-initiated Clinical Cancer Studies" to projects led by Mælandsmo, Loge and Myklebost ]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12400</link>
<description><![CDATA[The Programme for Publicly-initiated Clinical Cancer Studies provides support to research projects that will increase understanding and thereby enhance the basis for effective decision-making within cancer treatment and care. The Research Council collaborates with the Norwegian Council for Quality Improvement and Priority Setting in Health Care on the selection of proposed topics for calls for proposals.The program has recently decided to distribute a sum amounting to about 65 mill NOK among three projects, all of which are led by scientists from the Norwegian Radium Hospital, OUS: Gunhild Mælandsmo, Jon Håvard Loge and Ola Myklebost. This was celebrated on Friday April 13th (photo from the celebration under "More").]]></description>
<dc:date>2012-04-13T13:46:00Z</dc:date>
</item>
<item>
<title><![CDATA[Llorente/Sandvig publish potential biomarkers for prostate cancer ]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12392</link>
<description><![CDATA[Alicia Llorente and Kirsten Sandvig, Department of Biochemistry, Institute for Cancer Research and Centre for Cancer Biomedicine, have recently published in Molecular and Cellular Proteomics (impact factor 8.4) a proteomic analysis of microvesicles released from a human prostate cancer cell line. Most of the 266 proteins identified have previously been reported to be present in vesicles released from other cell types, but several proteins seem to be specific for prostate cancer cells. Since microvesicles can reach biological fluids, these proteins are thus potentially useful as new non invasive biomarkers for detection, diagnosis and/or prognosis of prostate cancer.]]></description>
<dc:date>2012-04-10T14:11:00Z</dc:date>
</item>
<item>
<title><![CDATA[Mathias Toft appointed "Scientist of the Month" by "Helse Sør-Øst" for March 2012 ]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12384</link>
<description><![CDATA[The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by by calling special attention to a "Scientist of the month".For the month of March 2012, this honor goes to Mathias Toft from the Department of Neurology at the Division of Surgery and Clinical Neuroscience, Oslo University Hospital.]]></description>
<dc:date>2012-03-27T11:16:00Z</dc:date>
</item>
<item>
<title><![CDATA[Jonny Østensen and Sébastien Walchli Institute Seminar – March 21st]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12375</link>
<description><![CDATA[The institute seminar on Wednesday March 21st will be held by Jonny &Oslash;stensen from Inven2 and project winner of the Inven2 prize - &nbsp;S&eacute;bastien Walchli (photo), from Johanna Olweus' group at the Department of Immunology. Titles of their talks:&Oslash;stensen: "What characterizes innovative ideas?"W&auml;lchli: "A novel method of producing soluble TcRs"Time and place: 12.00, Auditorium, new research building, Montebello.]]></description>
<dc:date>2012-03-20T13:00:00Z</dc:date>
</item>
<item>
<title><![CDATA[Sverre Heim: Cytogenetic Analysis of Tumor Clonality  Institute Seminar – March 14th]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12359</link>
<description><![CDATA[The institute seminar on Wednesday March 14th will be held by Sverre Heim, Head of the Section for Cancer CytogeneticsTitle of his talk: Cytogenetic Analysis of Tumor Clonality Time and place: 12.00, Auditorium, new research building, Montebello.]]></description>
<dc:date>2012-03-12T12:24:00Z</dc:date>
</item>
<item>
<title><![CDATA[Prostate Cancer  Centre for Cancer Biomedicine (CCB) Mini-symposium March 28th]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12355</link>
<description><![CDATA[Centre for Cancer Biomedicine (CCB) will hold a mini-symposium on Prostate Cancer on Wednesday March 28th 2012 at 13 hrs.Venue: The Auditorium in the Research Building, The Norwegian Radium HospitalSpeakers: Karol Axcrona, Kathrine Lie, Fahri Saatcioglu, Alicia Llorente and Rolf SkotheimNB: registration March 22nd]]></description>
<dc:date>2012-03-09T14:04:00Z</dc:date>
</item>
<item>
<title><![CDATA[Marianne Koritzinsky and Daniel Zips Guest lectures Monday March 12th]]></title>
<link>http://www.ous-research.no/institute/?k=institute/news&amp;amp;aid=12352</link>
<description><![CDATA[Department of Radiation Biology welcomes you to the following two guest lectures on Monday March 12th in Seminarrom 1, Institute for Cancer Research (FOBY) at 13.00 &ndash; 14.00 by professors Marianne Koritzinsky and Daniel Zips. Titles of their talks:Koritzinsky: The unfolded protein response in cancer: oxygen sensor and therapeutic targetZips:&nbsp;EGFR targeting as theragnostic approach]]></description>
<dc:date>2012-03-08T14:22:00Z</dc:date>
</item>

	</channel>

</rss>

